Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1994-7-7
pubmed:abstractText
We studied whether primary cultured porcine brain capillary endothelial cells (PBCEC) respond to bradykinin with an enhanced intracellular cytosolic calcium concentration [Ca2+]i with subsequent formation of nitric oxide (NO) and prostacyclin (PGI2). In addition we examined whether these cells synthetize and release kinins that may accumulate during angiotensin-converting enzyme (ACE) inhibition. [Ca2+]i was assessed by the fluorescent dye Fura-2, NO formation by determination of intracellular cyclic GMP and PGI2 by a specific radioimmunoassay for 6-ketoprostaglandin F1 alpha. Bradykinin and the ACE inhibitor ramiprilat concentration-dependently increased the formation of cyclic GMP which was completely prevented by the stereospecific inhibitor of NO synthase, NG-nitro-L-arginine. Also the specific B2-kinin receptor antagonist icatibant (Hoe 140) abolished the increase in cyclic GMP as well as the ramiprilat-induced increase in PGI2 formation. The data demonstrate the existence of B2-kinin receptors and ACE activity in PBCEC. Moreover PBCEC are capable of producing and releasing kinins in amounts that lead via stimulation of B2-kinin receptors to an enhanced [Ca2+]i as well as NO and PGI2 synthesis and release, provided that degradation of kinins is prevented by inhibition of endothelial ACE activity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-3-isobutylxanthine, http://linkedlifedata.com/resource/pubmed/chemical/6-Ketoprostaglandin F1 alpha, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Arginine, http://linkedlifedata.com/resource/pubmed/chemical/Bradykinin, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP, http://linkedlifedata.com/resource/pubmed/chemical/Epoprostenol, http://linkedlifedata.com/resource/pubmed/chemical/Fura-2, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitroarginine, http://linkedlifedata.com/resource/pubmed/chemical/Ramipril, http://linkedlifedata.com/resource/pubmed/chemical/ramiprilat
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0006-8993
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
638
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
261-6
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:7515323-1-Methyl-3-isobutylxanthine, pubmed-meshheading:7515323-6-Ketoprostaglandin F1 alpha, pubmed-meshheading:7515323-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:7515323-Animals, pubmed-meshheading:7515323-Arginine, pubmed-meshheading:7515323-Bradykinin, pubmed-meshheading:7515323-Calcium, pubmed-meshheading:7515323-Capillaries, pubmed-meshheading:7515323-Cells, Cultured, pubmed-meshheading:7515323-Cerebrovascular Circulation, pubmed-meshheading:7515323-Cyclic GMP, pubmed-meshheading:7515323-Cytosol, pubmed-meshheading:7515323-Dose-Response Relationship, Drug, pubmed-meshheading:7515323-Endothelium, Vascular, pubmed-meshheading:7515323-Epoprostenol, pubmed-meshheading:7515323-Fura-2, pubmed-meshheading:7515323-Kinetics, pubmed-meshheading:7515323-Nitric Oxide, pubmed-meshheading:7515323-Nitroarginine, pubmed-meshheading:7515323-Ramipril, pubmed-meshheading:7515323-Swine
pubmed:year
1994
pubmed:articleTitle
Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
pubmed:affiliation
Hoechst AG, SBU Cardiovascular Agents, Frankfurt/Main, Germany.
pubmed:publicationType
Journal Article